Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Savara (SVRA) Financials

Savara logo
$5.02 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$5.19 +0.17 (+3.45%)
As of 05/22/2026 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Savara

Annual Income Statements for Savara

This table shows Savara's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -9.18 -11 -31 -62 -78 -50 -43 -38 -55 -96 -119
Consolidated Net Income / (Loss)		 -9.00 -11 -30 -62 -78 -50 -43 -38 -55 -96 -119
Net Income / (Loss) Continuing Operations		 -9.00 -11 -30 -62 -78 -50 -43 -38 -55 -96 -119
Total Pre-Tax Income 		-9.00 -11 -33 -69 -79 -50 -44 -39 -55 -97 -120
Total Operating Income		 -5.92 -11 -30 -70 -79 -49 -41 -39 -60 -103 -124
Total Gross Profit		 0.05 0.40 0.00 0.00 0.00 0.26 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.05 0.40 0.00 0.00 0.00 0.26 0.00 0.00 0.00 0.00 0.00
Operating Revenue		 0.05 0.40 - - 0.00 0.26 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 5.98 11 30 70 79 50 41 39 60 103 124
Selling, General & Admin Expense		 1.65 2.82 11 11 13 14 12 11 16 25 42
Research & Development Expense		 4.32 8.18 19 37 39 35 29 28 44 78 81
Depreciation Expense		 0.01 0.35 0.36 0.53 0.31 0.26 0.14 0.03 0.08 0.13 0.09
Total Other Income / (Expense), net		 -3.08 -0.33 -3.48 1.47 -0.36 -0.32 -2.38 -0.11 4.51 6.52 3.93
Interest Expense		 2.81 0.45 1.82 - - - - - - 0.00 0.55
Interest & Investment Income		 - - -1.16 0.01 -0.07 -1.48 -2.28 -0.09 4.44 6.47 4.16
Other Income / (Expense), net		 -0.27 0.12 -0.50 1.46 -0.29 1.17 -0.10 -0.02 0.08 0.05 0.31
Income Tax Expense		 - -0.36 -3.63 -7.06 -1.21 - -0.84 -0.80 -0.80 -0.80 -0.78
Basic Earnings per Share		 ($9.48) ($5.62) ($1.76) ($1.85) ($1.95) ($0.84) ($0.32) ($0.25) ($0.33) ($0.48) ($0.53)
Weighted Average Basic Shares Outstanding		 968.81K 1.96M 17.52M 33.30M 40.03M 59.31M 133.92M 152.77M 165.20M 198.19M 222.39M
Diluted Earnings per Share		 ($9.48) ($5.62) ($1.76) ($1.85) ($1.95) ($0.84) ($0.32) ($0.25) ($0.33) ($0.48) ($0.53)
Weighted Average Diluted Shares Outstanding		 968.81K 1.96M 17.52M 33.30M 40.03M 59.31M 133.92M 152.77M 165.20M 198.19M 222.39M
Weighted Average Basic & Diluted Shares Outstanding		 968.81K 1.96M 17.52M 33.30M 40.03M 59.31M 133.92M 114.06M 138.15M 172.63M 204.66M

Quarterly Income Statements for Savara

This table shows Savara's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -17 -16 -20 -22 -24 -29 -27 -30 -30 -32 -37
Consolidated Net Income / (Loss)		 -17 -16 -20 -22 -24 -29 -27 -30 -30 -32 -37
Net Income / (Loss) Continuing Operations		 -17 -16 -20 -22 -24 -29 -27 -30 -30 -32 -37
Total Pre-Tax Income 		0.00 -33 -20 0.00 0.00 -53 0.00 0.00 0.00 -93 0.00
Total Operating Income		 -18 -18 -22 -23 -26 -31 -28 -31 -30 -33 -39
Total Gross Profit		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Operating Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 18 18 22 23 26 31 28 31 30 33 39
Selling, General & Admin Expense		 4.15 4.85 5.64 5.54 6.01 7.85 9.25 11 9.63 13 16
Research & Development Expense		 14 13 17 18 20 23 19 21 21 21 23
Depreciation Expense		 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 -0.01 0.02
Total Other Income / (Expense), net		 1.45 1.53 2.13 0.95 2.11 2.13 1.01 1.04 0.69 0.40 0.85
Interest Expense		 - - 0.00 0.00 0.00 - 0.55 0.00 0.00 - 0.00
Interest & Investment Income		 1.44 1.52 1.35 1.07 2.13 1.91 1.50 0.92 0.55 1.20 1.06
Other Income / (Expense), net		 0.00 0.01 0.78 -0.13 -0.02 0.22 0.06 0.12 0.15 -0.80 -0.20
Income Tax Expense		 0.00 - 0.00 0.00 0.00 - -0.78 0.00 0.00 -0.78 -0.85
Basic Earnings per Share		 ($0.10) ($0.09) ($0.11) ($0.12) ($0.11) ($0.14) ($0.12) ($0.14) ($0.14) ($0.13) ($0.15)
Weighted Average Basic Shares Outstanding		 174.70M 165.20M 182.55M 182.58M 211.85M 198.19M 216.15M 216.43M 216.46M 222.39M 253.28M
Diluted Earnings per Share		 ($0.10) ($0.09) ($0.11) ($0.12) ($0.11) ($0.14) ($0.12) ($0.14) ($0.14) ($0.13) ($0.15)
Weighted Average Diluted Shares Outstanding		 174.70M 165.20M 182.55M 182.58M 211.85M 198.19M 216.15M 216.43M 216.46M 222.39M 253.28M
Weighted Average Basic & Diluted Shares Outstanding		 135.34M 138.15M 138.19M 164.60M 171.62M 172.63M 172.84M 172.84M 203.47M 204.66M 204.93M

Annual Cash Flow Statements for Savara

This table details how cash moves in and out of Savara's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 4.00 -3.31 8.75 2.18 26 -27 11 18 -26 -11 18
Net Cash From Operating Activities		 -4.78 -8.37 -28 -39 -45 -40 -40 -35 -51 -89 -101
Net Cash From Continuing Operating Activities		 -4.78 -8.37 -28 -39 -45 -40 -40 -35 -51 -89 -101
Net Income / (Loss) Continuing Operations		 -9.00 -11 -30 -62 -78 -50 -43 -38 -55 -96 -119
Consolidated Net Income / (Loss)		 -9.00 -11 -30 -62 -78 -50 -43 -38 -55 -96 -119
Depreciation Expense		 0.01 0.35 0.36 0.53 0.31 0.26 0.14 0.03 0.08 0.13 0.09
Amortization Expense		 - - 0.40 0.47 1.28 1.00 2.39 0.55 -4.71 -5.03 -2.26
Non-Cash Adjustments To Reconcile Net Income		 4.20 0.13 -1.35 27 30 10 3.26 2.06 4.20 9.86 15
Changes in Operating Assets and Liabilities, net		 0.02 2.08 2.12 -6.15 1.11 -1.71 -2.85 0.96 4.07 1.83 5.00
Net Cash From Investing Activities		 0.00 -0.01 -69 -14 16 9.05 -69 53 -57 -40 -18
Net Cash From Continuing Investing Activities		 0.00 -0.01 -69 -14 16 9.05 -69 53 -57 -40 -18
Purchase of Property, Plant & Equipment		 - -0.01 -0.50 -0.14 -0.15 -0.05 -0.06 -0.01 -0.30 -0.03 -0.02
Purchase of Investments		 - - -77 -122 -123 -86 -161 -89 -194 -205 -205
Sale and/or Maturity of Investments		 - - 4.80 109 139 98 92 142 137 165 186
Net Cash From Financing Activities		 8.77 5.12 106 55 55 3.69 121 0.09 83 118 138
Net Cash From Continuing Financing Activities		 8.77 5.12 106 55 55 3.69 121 0.09 83 118 138
Repayment of Debt		 - -0.08 -0.46 -0.55 0.00 -0.51 0.00 -26 0.00 0.00 -27
Repurchase of Common Equity		 - - - - - 0.00 -3.99 -0.00 -1.21 -1.00 -5.14
Issuance of Debt		 - 4.42 15 9.37 0.04 - 0.00 26 0.00 0.00 30
Issuance of Common Equity		 - - 91 46 55 4.12 125 0.00 84 118 140
Other Financing Activities, net		 - 0.00 0.39 0.06 0.11 0.09 0.02 0.00 0.28 0.40 0.35
Effect of Exchange Rate Changes		 - -0.05 - - - - -0.14 -0.09 -0.12 -0.01 -0.28
Cash Interest Paid		 - - 0.73 1.41 2.10 2,470 1.97 1.61 2.04 2.12 3.20

Quarterly Cash Flow Statements for Savara

This table details how cash moves in and out of Savara's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 4.95 -1.11 -9.80 7.08 -2.44 -6.30 4.43 -2.12 -1.16 17 5.61
Net Cash From Operating Activities		 -13 -16 -21 -22 -23 -23 -27 -26 -23 -25 -33
Net Cash From Continuing Operating Activities		 -13 -16 -21 -22 -23 -23 -27 -26 -23 -25 -33
Net Income / (Loss) Continuing Operations		 -17 -16 -20 -22 -24 -29 -27 -30 -30 -32 -37
Consolidated Net Income / (Loss)		 -17 -16 -20 -22 -24 -29 -27 -30 -30 -32 -37
Depreciation Expense		 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 -0.01 0.02
Amortization Expense		 -1.41 -1.64 -1.27 -1.02 -1.37 -1.51 -1.08 -0.67 -0.30 -0.21 -0.41
Non-Cash Adjustments To Reconcile Net Income		 0.99 1.45 2.26 2.32 2.39 3.02 3.56 2.71 3.47 5.24 11
Changes in Operating Assets and Liabilities, net		 3.82 0.65 -1.34 -1.58 0.70 4.06 -3.06 2.07 3.83 2.16 -6.14
Net Cash From Investing Activities		 -57 6.57 11 30 -98 18 29 24 21 -94 39
Net Cash From Continuing Investing Activities		 -57 6.57 11 30 -98 18 29 24 21 -94 39
Purchase of Property, Plant & Equipment		 -0.04 -0.02 -0.01 -0.02 -0.00 0.01 -0.00 -0.02 -0.00 -0.00 -0.05
Purchase of Investments		 -95 -39 -31 -3.44 -139 -32 -15 -40 -23 -127 0.00
Sale and/or Maturity of Investments		 38 45 42 33 41 50 44 64 44 34 39
Net Cash From Financing Activities		 75 7.90 0.05 0.06 118 -0.84 2.32 -0.05 -0.02 136 -0.20
Net Cash From Continuing Financing Activities		 75 7.90 0.05 0.06 118 -0.84 2.32 -0.05 -0.02 136 -0.20
Repayment of Debt		 - - 0.00 - - - -27 - 0.00 - 0.00
Repurchase of Common Equity		 -0.18 -1.03 -0.00 -0.00 -0.09 -0.90 -0.22 -0.11 -0.02 -4.79 -0.24
Issuance of Debt		 - - 0.00 - - - 30 - - - 0.00
Issuance of Common Equity		 75 8.83 0.00 - 118 -0.00 0.00 - - 140 0.00
Other Financing Activities, net		 0.06 0.09 0.05 0.06 0.24 0.06 0.17 0.07 - 0.12 0.05
Other Net Changes in Cash		 - - - - - - - - - - 0.07
Cash Interest Paid		 0.53 0.54 0.54 0.54 0.54 0.51 1.33 0.50 0.72 0.66 0.62

Annual Balance Sheets for Savara

This table presents Savara's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 54 29 160 152 136 98 177 140 178 213 253
Total Current Assets		 42 15 98 113 124 85 165 129 166 202 242
Cash & Equivalents		 23 13 22 24 50 23 34 52 27 15 33
Short-Term Investments		 18 0.00 72 87 72 59 127 74 136 181 203
Prepaid Expenses		 1.27 0.84 3.55 2.51 2.31 2.93 3.83 3.08 3.63 5.81 5.91
Plant, Property, & Equipment, net		 0.23 0.79 0.93 0.52 0.35 0.16 0.07 0.05 0.27 0.17 0.10
Total Noncurrent Assets		 12 14 61 38 12 12 12 11 11 11 12
Other Noncurrent Operating Assets		 8.73 10 34 12 12 12 12 11 11 11 12
Total Liabilities & Shareholders' Equity		 54 29 160 152 136 98 177 140 178 213 253
Total Liabilities		 30 21 40 44 35 33 32 32 37 41 50
Total Current Liabilities		 23 3.46 6.02 7.25 11 8.17 15 5.87 11 15 20
Accounts Payable		 2.60 0.54 2.78 3.88 3.41 2.60 1.44 1.33 3.50 4.55 5.76
Accrued Expenses		 8.15 2.48 2.97 3.38 5.47 5.58 4.88 4.53 7.09 10 15
Total Noncurrent Liabilities		 7.16 17 34 37 24 25 17 26 27 27 30
Long-Term Debt		 3.73 3.47 15 25 23 25 17 26 26 27 30
Other Noncurrent Operating Liabilities		 - 11 12 12 0.51 0.08 0.12 0.05 0.25 0.09 0.00
Commitments & Contingencies		 0.00 - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 24 -36 119 108 102 64 144 108 140 171 203
Total Preferred & Common Equity		 24 -36 119 108 102 64 144 108 140 171 203
Total Common Equity		 24 -36 119 108 102 64 144 108 140 171 203
Common Stock		 299 3.12 187 238 310 321 445 447 534 661 811
Retained Earnings		 -275 -38 -68 -130 -208 -258 -301 -339 -393 -489 -608
Accumulated Other Comprehensive Income / (Loss)		 -0.02 -0.59 0.96 0.20 -0.02 0.94 0.01 -0.61 -0.27 -0.75 -0.09

Quarterly Balance Sheets for Savara

This table presents Savara's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 148 129 120 182 158 140 239 189 164 141 222
Total Current Assets		 137 118 108 170 146 128 226 177 151 128 209
Cash & Equivalents		 120 34 23 28 17 24 21 20 17 16 39
Short-Term Investments		 14 81 82 141 126 98 198 153 129 108 164
Prepaid Expenses		 2.99 2.85 2.72 1.85 3.14 6.18 6.96 4.94 4.55 3.81 6.49
Plant, Property, & Equipment, net		 0.06 0.05 0.26 0.28 0.25 0.24 0.21 0.14 0.12 0.09 0.13
Total Noncurrent Assets		 11 12 12 12 12 12 12 12 13 13 12
Other Noncurrent Operating Assets		 11 12 12 12 12 12 12 12 13 13 12
Total Liabilities & Shareholders' Equity		 148 129 120 182 158 140 239 189 164 141 222
Total Liabilities		 31 31 32 36 36 38 39 41 43 47 46
Total Current Liabilities		 5.16 4.92 5.89 8.96 9.81 11 13 12 14 17 16
Accounts Payable		 0.89 1.57 2.50 3.22 2.85 3.39 4.61 5.56 4.75 4.14 4.50
Accrued Expenses		 4.27 3.35 3.38 5.74 6.96 7.90 8.18 6.34 8.88 13 11
Total Noncurrent Liabilities		 26 26 26 27 27 27 27 30 30 30 30
Long-Term Debt		 26 26 26 26 26 26 27 30 30 30 30
Other Noncurrent Operating Liabilities		 0.07 0.04 0.02 0.28 0.21 0.17 0.13 0.04 0.00 0.00 0.00
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 117 98 88 147 122 102 199 148 120 94 176
Total Preferred & Common Equity		 117 98 88 147 122 102 199 148 120 94 176
Total Common Equity		 117 98 88 147 122 102 199 148 120 94 176
Common Stock		 446 448 449 525 536 539 659 664 667 670 822
Retained Earnings		 -328 -349 -361 -377 -414 -436 -460 -516 -546 -576 -645
Accumulated Other Comprehensive Income / (Loss)		 -1.61 -0.46 -0.62 -0.94 -0.74 -0.88 0.30 -0.63 -0.22 -0.16 -0.43

Annual Metrics And Ratios for Savara

This table displays calculated financial ratios and metrics derived from Savara's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 163,614,297.00 238,230,454.00 30,500,693.00 35,128,771.00 41,210,386.00 54,141,275.00 113,868,809.00 - - - 203,467,845.00
DEI Adjusted Shares Outstanding		 163,614,297.00 238,230,454.00 30,500,693.00 35,128,771.00 41,210,386.00 54,141,275.00 113,868,809.00 - - - 203,467,845.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.06 -0.05 -1.01 -1.75 -1.90 -0.92 -0.38 - - - -0.58
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 -4.15 -7.66 -21 -49 -55 -35 -29 -27 -42 -72 -86
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -25.19% -36.47% -37.11%
Earnings before Interest and Taxes (EBIT)		 -6.19 -11 -30 -69 -79 -48 -42 -39 -60 -103 -123
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -6.18 -10 -30 -68 -78 -47 -39 -38 -65 -108 -125
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -0.43 -9.12 -62 -31 -38 -37 -31 -26 -38 -70 -82
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -2.35 -0.90 40 22 5.05 7.30 8.98 7.98 4.40 1.74 -2.66
Increase / (Decrease) in Invested Capital		 -3.72 1.45 41 -19 -17 2.25 1.68 -1.00 -3.58 -2.66 -4.40
Book Value per Share		 $0.15 ($0.15) $3.91 $3.08 $2.47 $1.19 $1.27 $0.95 $1.04 $1.00 $1.00
Tangible Book Value per Share		 $0.13 ($0.16) $3.02 $2.31 $2.47 $1.19 $1.27 $0.95 $1.04 $1.00 $1.00
Total Capital		 39 12 135 133 127 89 170 134 167 198 233
Total Debt		 15 4.49 15 25 25 25 26 26 26 27 30
Total Long-Term Debt		 3.75 4.05 15 25 23 25 17 26 26 27 30
Net Debt		 -26 -8.88 -79 -86 -97 -57 -136 -100 -136 -170 -206
Capital Expenditures (CapEx)		 0.00 0.01 0.50 0.14 0.15 0.05 0.06 0.01 0.30 0.03 0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -11 -1.77 -2.20 -4.74 -6.57 -5.24 -2.50 -2.79 -6.97 -8.92 -14
Debt-free Net Working Capital (DFNWC)		 30 12 92 106 115 77 159 123 155 187 221
Net Working Capital (NWC)		 19 11 92 106 113 77 150 123 155 187 221
Net Nonoperating Expense (NNE)		 4.85 3.26 8.83 12 23 15 14 11 13 24 32
Net Nonoperating Obligations (NNO)		 -26 -8.88 -79 -86 -97 -57 -136 -100 -136 -170 -206
Total Depreciation and Amortization (D&A)		 0.01 0.35 0.76 0.99 1.59 1.26 2.52 0.58 -4.64 -5.04 -2.17
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.25) ($0.17) ($1.76) ($1.85) ($1.95) ($0.84) ($0.32) ($0.25) ($0.33) ($0.48) ($0.53)
Adjusted Weighted Average Basic Shares Outstanding		 192.84M 254.75M 30.60M 35.34M 50.84M 54.24M 114.04M 152.77M 165.20M 198.19M 222.39M
Adjusted Diluted Earnings per Share		 ($0.25) ($0.17) ($1.76) ($1.85) ($1.95) ($0.84) ($0.32) ($0.25) ($0.33) ($0.48) ($0.53)
Adjusted Weighted Average Diluted Shares Outstanding		 192.84M 254.75M 30.60M 35.34M 50.84M 54.24M 114.04M 152.77M 165.20M 198.19M 222.39M
Adjusted Basic & Diluted Earnings per Share		 ($0.25) ($0.17) ($1.76) ($1.85) ($1.95) ($0.84) ($0.32) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 162.22M 208.48M 17.52M 33.30M 40.03M 59.31M 133.92M 114.06M 138.15M 172.63M 204.66M
Normalized Net Operating Profit after Tax (NOPAT)		 -4.15 -7.66 -21 -34 -37 -35 -29 -27 -42 -72 -86
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Savara

This table displays calculated financial ratios and metrics derived from Savara's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - 172,633,140.00 172,836,922.00 172,836,922.00 203,467,845.00 204,657,499.00
DEI Adjusted Shares Outstanding		 - - - - - - 172,633,140.00 172,836,922.00 172,836,922.00 203,467,845.00 204,657,499.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - -0.15 -0.18 -0.17 -0.16 -0.18
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
EBITDA Growth		 -87.26% -72.19% -83.73% -86.81% -42.72% -68.75% -24.88% -31.12% -9.44% - -34.50%
EBIT Growth		 -71.14% -61.40% -86.18% -91.29% -46.19% -75.72% -27.15% -34.34% -14.15% - -38.13%
NOPAT Growth		 -71.28% -62.11% -85.56% -89.76% -46.07% -76.82% -26.52% -35.58% -14.79% - -37.12%
Net Income Growth		 -59.82% -56.30% -92.73% -94.38% -46.08% -80.41% -30.93% -36.68% -21.91% - -39.96%
EPS Growth		 -42.86% -28.57% -57.14% -71.43% -10.00% -55.56% -9.09% -16.67% -27.27% - -25.00%
Operating Cash Flow Growth		 -61.24% -80.36% -71.66% -118.99% -72.25% -49.21% -31.70% -16.74% 0.61% - -21.54%
Free Cash Flow Firm Growth		 -48.90% -32.57% -48.97% -109.85% -132.21% -118.69% -72.30% -33.98% 28.71% - -31.77%
Invested Capital Growth		 -45.85% -44.85% -45.61% -23.43% 41.25% -60.44% -6.88% -44.86% -103.39% - -31.60%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
EBITDA Q/Q Growth		 -49.28% 1.04% -24.10% -2.41% -14.04% -17.02% 11.70% -11.60% 4.97% - -14.94%
EBIT Q/Q Growth		 -48.04% 2.36% -27.69% -3.64% -13.13% -17.36% 10.87% -13.52% 3.87% - -14.55%
NOPAT Q/Q Growth		 -47.65% 2.29% -27.48% -3.18% -13.66% -18.28% 8.79% -10.57% 3.77% - -16.68%
Net Income Q/Q Growth		 -45.06% 3.01% -26.38% -9.32% -9.01% -19.78% 8.28% -14.12% 2.76% - -15.66%
EPS Q/Q Growth		 -42.86% 10.00% -22.22% -9.09% 8.33% -27.27% 14.29% -16.67% 0.00% - -15.38%
Operating Cash Flow Q/Q Growth		 -28.12% -18.56% -32.31% -8.97% -0.77% -2.70% -16.79% 3.41% 14.21% - -31.88%
Free Cash Flow Firm Q/Q Growth		 -29.58% -0.05% -29.46% -25.03% -43.39% 5.78% -2.00% 2.77% 23.70% - -35.62%
Invested Capital Q/Q Growth		 -47.72% -3.78% 18.93% 27.99% -3.55% -73.05% 179.95% -24.21% -105.93% - 225.24%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Tax Burden Percent		 0.00% 49.24% 96.23% 100.00% 0.00% 54.50% 100.00% 0.00% 0.00% - 0.00%
Interest Burden Percent		 0.00% 185.60% 93.99% 95.40% 0.00% 172.15% 96.55% 0.00% 0.00% - 0.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Equity (ROE)		 -37.18% -44.08% -58.59% -79.48% -47.95% -61.50% -75.77% -99.30% -78.74% - -79.95%
Cash Return on Invested Capital (CROIC)		 -513.07% -620.72% -604.03% -710.61% -1,171.61% -2,265.62% -1,504.73% -1,523.70% 0.00% - -2,249.79%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Common Equity (ROCE)		 -37.18% -44.08% -58.59% -79.48% -47.95% -61.50% -75.77% -99.30% -78.74% - -79.95%
Return on Equity Simple (ROE_SIMPLE)		 -33.37% 0.00% -52.92% -74.01% -41.60% 0.00% -69.11% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 -13 -12 -16 -16 -18 -22 -20 -22 -21 -23 -27
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Net Nonoperating Expense Percent (NNEP)		 -3.17% -3.19% -4.50% -6.91% -3.46% -4.73% -5.19% -7.92% -5.83% - -6.33%
Return On Investment Capital (ROIC_SIMPLE)		 - -7.40% - - - -11.02% -11.22% -14.66% -17.06% -10.04% -13.24%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings before Interest and Taxes (EBIT)		 -18 -18 -22 -23 -26 -31 -28 -31 -30 -34 -39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -19 -19 -24 -24 -28 -32 -29 -32 -30 -34 -40
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.49 4.53 5.65 5.47 3.50 3.07 3.23 3.27 6.54 - 6.35
Price to Tangible Book Value (P/TBV)		 3.49 4.53 5.65 5.47 3.50 3.07 3.23 3.27 6.54 - 6.35
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)		 80.67 113.64 109.16 68.95 78.16 205.15 68.78 75.06 0.00 - 283.36
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.18 0.19 0.22 0.26 0.13 0.16 0.20 0.25 0.32 - 0.17
Long-Term Debt to Equity		 0.18 0.19 0.22 0.26 0.13 0.16 0.20 0.25 0.32 - 0.17
Financial Leverage		 -0.95 -0.95 -0.93 -0.92 -0.97 -0.98 -0.96 -0.95 -0.98 - -0.97
Leverage Ratio		 1.25 1.28 1.31 1.37 1.22 1.25 1.29 1.37 1.29 - 1.27
Compound Leverage Factor		 0.00 2.37 1.23 1.31 0.00 2.16 1.24 0.00 0.00 - 0.00
Debt to Total Capital		 15.21% 15.80% 17.82% 20.66% 11.75% 13.44% 16.65% 19.75% 23.98% - 14.59%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital		 15.21% 15.80% 17.82% 20.66% 11.75% 13.44% 16.65% 19.75% 23.98% - 14.59%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 84.79% 84.20% 82.18% 79.34% 88.25% 86.56% 83.35% 80.25% 76.02% - 85.41%
Debt to EBITDA		 -0.47 -0.41 -0.35 -0.31 -0.28 -0.25 -0.26 -0.24 -0.24 - -0.22
Net Debt to EBITDA		 2.51 2.11 1.55 1.10 2.03 1.57 1.26 0.96 0.76 - 1.27
Long-Term Debt to EBITDA		 -0.47 -0.41 -0.35 -0.31 -0.28 -0.25 -0.26 -0.24 -0.24 - -0.22
Debt to NOPAT		 -0.71 -0.63 -0.54 -0.47 -0.42 -0.37 -0.39 -0.36 -0.35 - -0.32
Net Debt to NOPAT		 3.81 3.24 2.37 1.67 3.07 2.35 1.87 1.42 1.11 - 1.84
Long-Term Debt to NOPAT		 -0.71 -0.63 -0.54 -0.47 -0.42 -0.37 -0.39 -0.36 -0.35 - -0.32
Altman Z-Score		 6.46 7.88 8.24 4.89 8.62 4.99 3.67 1.17 2.48 - 11.09
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 18.98 15.66 14.90 11.31 17.70 13.73 14.91 11.08 7.65 - 13.47
Quick Ratio		 18.77 15.32 14.58 10.77 17.16 13.33 14.50 10.75 7.42 - 13.05
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -8.76 -8.76 -11 -14 -20 -19 -20 -19 -14 -19 -26
Operating Cash Flow to CapEx		 -30,604.65% -65,012.50% -206,440.00% -107,119.05% -755,600.00% 0.00% -906,300.00% -175,073.33% -1,126,500.00% - -61,196.30%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -35.80 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -49.80 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -49.80 0.00 0.00 - 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4.57 4.40 5.23 6.70 6.46 1.74 4.87 3.69 -0.22 -2.66 3.33
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Increase / (Decrease) in Invested Capital		 -3.87 -3.58 -4.39 -2.05 1.89 -2.66 -0.36 -3.01 -6.68 -4.40 -1.54
Enterprise Value (EV)		 369 500 571 462 505 357 335 277 522 - 945
Market Capitalization		 511 636 688 557 698 527 478 394 617 - 1,117
Book Value per Share		 $1.08 $1.04 $0.88 $0.74 $1.21 $1.00 $0.86 $0.70 $0.55 $1.00 $0.86
Tangible Book Value per Share		 $1.08 $1.04 $0.88 $0.74 $1.21 $1.00 $0.86 $0.70 $0.55 $1.00 $0.86
Total Capital		 173 167 148 128 226 198 177 150 124 233 206
Total Debt		 26 26 26 26 27 27 30 30 30 30 30
Total Long-Term Debt		 26 26 26 26 27 27 30 30 30 30 30
Net Debt		 -142 -136 -117 -95 -193 -170 -143 -117 -95 -206 -173
Capital Expenditures (CapEx)		 0.04 0.02 0.01 0.02 0.00 -0.01 0.00 0.02 0.00 0.00 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -7.12 -6.97 -6.67 -5.11 -5.83 -8.92 -6.95 -9.08 -13 -14 -9.05
Debt-free Net Working Capital (DFNWC)		 161 155 136 116 214 187 166 137 111 221 194
Net Working Capital (NWC)		 161 155 136 116 214 187 166 137 111 221 194
Net Nonoperating Expense (NNE)		 3.97 3.76 4.61 6.01 5.80 7.22 6.73 8.39 8.38 8.84 9.99
Net Nonoperating Obligations (NNO)		 -142 -136 -117 -95 -193 -170 -143 -117 -95 -206 -173
Total Depreciation and Amortization (D&A)		 -1.38 -1.60 -1.24 -0.99 -1.34 -1.48 -1.05 -0.64 -0.26 -0.22 -0.38
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.10) ($0.09) ($0.11) ($0.12) ($0.11) ($0.14) ($0.12) ($0.14) ($0.14) ($0.13) ($0.15)
Adjusted Weighted Average Basic Shares Outstanding		 164.34M 165.20M 182.55M 182.58M 211.85M 198.19M 216.15M 216.43M 216.46M 222.39M 253.28M
Adjusted Diluted Earnings per Share		 ($0.10) ($0.09) ($0.11) ($0.12) ($0.11) ($0.14) ($0.12) ($0.14) ($0.14) ($0.13) ($0.15)
Adjusted Weighted Average Diluted Shares Outstanding		 164.34M 165.20M 182.55M 182.58M 211.85M 198.19M 216.15M 216.43M 216.46M 222.39M 253.28M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 135.34M 138.15M 138.19M 164.60M 171.62M 172.63M 172.84M 172.84M 203.47M 204.66M 204.93M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -12 -16 -16 -18 -22 -20 -22 -21 -23 -27
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -50.53 0.00 0.00 - 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -36.46 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -50.54 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -36.46 0.00 0.00 - 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio		 -0.38% -2.21% -1.87% -1.61% -1.35% -1.04% -1.18% -1.20% -1.08% - -3.99%

Financials Breakdown Chart

Key Financial Trends

Savara Inc. (SVRA) remains in a development-stage financial profile, with little to no quarterly operating revenue in the period covered and persistent net losses. The company continues to rely on financing activity to fund operations, while occasionally generating liquidity from investing activities. The balance sheet shows a positive equity base and meaningful cash and investments that provide liquidity runway, but the ongoing cash burn underscores the importance of continued external financing.

  • Large equity financing in Q4 2025: Issuance of Common Equity of about $140.2 million, with net cash from continuing financing activities totaling roughly $135.6 million in that quarter, significantly boosting liquidity.
  • Non-operating liquidity from investing activities in Q3 2025: Sale/maturity of investments totaling about $44.4 million, contributing to a net cash from investing activities of about $21.5 million, helping offset operating cash burn.
  • Strong cash & short-term investment position in Q3 2025: Approximately $16.3 million in cash and $108.1 million in short-term investments, totaling around $124 million in liquid assets on the balance sheet.
  • Positive equity cushion: The balance sheet shows a positive total equity base around $94 million in the recent period, providing a cushion to support ongoing R&D and clinical development efforts.
  • No operating revenue reported in Q4 2025 (and similar near-term quarters), with ongoing net losses across multiple quarters due to high SG&A and R&D spend.
  • Operating expenses remain elevated (SG&A and R&D in the tens of millions each quarter), driving negative pre-tax income in several periods.
  • Some quarters show restated or slightly revised figures (e.g., prior-year restatements in 2023–2024 data), indicating ongoing accounting adjustments typical for late-stage biotech reporting.
  • Persistent net losses: Net income deteriorates across recent quarters (e.g., Q4 2025 net income of about -$32.2 million; Q3 2025 around -$29.6 million), with EPS about -$0.13 to -$0.14 per share.
  • Operating cash flow is negative in the newer quarters, signaling ongoing cash burn from core operations without meaningful product revenue.
  • Reliance on equity financing: Repeated reliance on stock issuance to fund operations raises dilution risk for existing shareholders and may pressure future capital-raising terms.
05/25/26 04:44 PM ETAI Generated. May Contain Errors.

Savara Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Savara's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Savara's net income appears to be on an upward trend, with a most recent value of -$118.84 million in 2025, rising from -$9.00 million in 2015. The previous period was -$95.88 million in 2024. View Savara's forecast to see where analysts expect Savara to go next.

Savara's total operating income in 2025 was -$123.55 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $123.55 million

Over the last 10 years, Savara's total revenue changed from $54 thousand in 2015 to $0.00 in 2025, a change of -100.0%.

Savara's total liabilities were at $50.30 million at the end of 2025, a 21.4% increase from 2024, and a 65.9% increase since 2015.

In the past 10 years, Savara's cash and equivalents has ranged from $13.37 million in 2016 to $52.10 million in 2022, and is currently $33.18 million as of their latest financial filing in 2025.

Over the last 10 years, Savara's book value per share changed from 0.15 in 2015 to 1.00 in 2025, a change of 583.8%.


Related Companies

Financial statements for NASDAQ:SVRA last updated on 5/14/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel